Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Versartis Inc (VSAR)

Versartis Inc (VSAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,126
  • Shares Outstanding, K 36,240
  • Annual Sales, $ 40,000 K
  • Annual Income, $ -84,980 K
  • 60-Month Beta 1.94
  • Price/Sales 1,096.29
  • Price/Cash Flow N/A
  • Price/Book 0.62
Trade VSAR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.35
  • Most Recent Earnings $-1.40 on 10/26/17
  • Latest Earnings Date 10/25/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.40
  • Growth Rate Est. (year over year) +71,457.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.14 +4.39%
on 10/12/18
1.60 -25.62%
on 09/27/18
-0.26 (-17.93%)
since 09/14/18
3-Month
1.14 +4.39%
on 10/12/18
2.10 -43.33%
on 07/24/18
-0.86 (-41.95%)
since 07/13/18
52-Week
1.14 +4.39%
on 10/12/18
2.76 -56.81%
on 10/19/17
-1.41 (-54.23%)
since 10/13/17

Most Recent Stories

More News
AmMax Bio Announces the Appointment of Biotechnology Executive, John Varian, as Independent Board Member

AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company developing innovative treatments with its proprietary dual anti-inflammatory/anti-fibrotic therapeutic platform targeting...

SLS : 1.0100 (-1.94%)
XOMA : 24.04 (+3.00%)
VSAR : 1.19 (-1.65%)

Business Summary

Versartis, Inc. operates as a biotechnology company. It develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. The Company is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase 2a clinical trials for the treatment of growth hormone...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.34
1st Resistance Point 1.27
Last Price 1.19
1st Support Level 1.15
2nd Support Level 1.10
3rd Support Level N/A

See More

52-Week High 2.76
Fibonacci 61.8% 2.14
Fibonacci 50% 1.95
Fibonacci 38.2% 1.76
Last Price 1.19
52-Week Low 1.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar